| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/22/2002 | CA2437402A1 New crystal forms of oxcarbazepine and processes for their preparation |
| 08/22/2002 | CA2437358A1 Agonists and antagonists of sphingosine-1-phosphate receptors |
| 08/22/2002 | CA2437333A1 Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin |
| 08/22/2002 | CA2437122A1 Quinazolines as mmp-13 inhibitors |
| 08/22/2002 | CA2437118A1 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 08/22/2002 | CA2436789A1 Identification of target-specific folding sites in peptides and proteins |
| 08/22/2002 | CA2436371A1 Bicyclic pyrimidine matrix metalloproteinase inhibitors |
| 08/22/2002 | CA2436259A1 Compounds effecting neuron remodeling and assays for same |
| 08/22/2002 | CA2436195A1 Laulimalide derivatives |
| 08/22/2002 | CA2436079A1 Heterocyclic inhibitors of glycine transporter 2 |
| 08/22/2002 | CA2435376A1 Isophthalic acid derivatives as matrix metalloproteinase inhibitors |
| 08/22/2002 | CA2434976A1 Medicament formulation containing a muscarinic agonist |
| 08/22/2002 | CA2433843A1 Molecules for disease detection and treatment |
| 08/22/2002 | CA2433778A1 Thieno'2,3-d pyrimidindione derivatives as matrix metalloproteinase inhibitors |
| 08/22/2002 | CA2433075A1 Benzo thiadiazine matrix metalloproteinase inhibitors |
| 08/22/2002 | CA2433057A1 Butyrylcholinesterase polypeptide variants with increased catalytic efficiency and methods of use |
| 08/22/2002 | CA2431033A1 Crystallization of igf-1 |
| 08/21/2002 | EP1233021A2 An inhibitor of Beta amyloid cleavage enzyme |
| 08/21/2002 | EP1232748A1 Substituted nitrobenzene derivatives as medicines and other useful uses thereof |
| 08/21/2002 | EP1232266A2 Polypeptides and nucleic acids encoding same |
| 08/21/2002 | EP1232259A1 Human galanin family proteins and polynucleotides encoding the same |
| 08/21/2002 | EP1232174A1 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 08/21/2002 | EP1232160A1 Spiro(2h-1-benzopyran-2,4'-piperidine)derivates as glycine transport inhibitors |
| 08/21/2002 | EP1232159A1 Beta-amyloid peptide inhibitors |
| 08/21/2002 | EP1232153A2 Imidazole derivatives and their use as raf kinase inhibitors |
| 08/21/2002 | EP1232150A1 Urea derivatives as anti-inflammatory agents |
| 08/21/2002 | EP1232144A2 Novel il-8 receptor antagonists |
| 08/21/2002 | EP1232141A1 Ethers of o-desmethyl venlafaxine |
| 08/21/2002 | EP1231982A2 Use of phthalazine derivatives |
| 08/21/2002 | EP1231944A2 Targeted delivery of therapeutic and diagnostic moieties |
| 08/21/2002 | EP1231916A2 Use of indirubine derivatives for making medicines |
| 08/21/2002 | EP1231913A2 Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds |
| 08/21/2002 | EP1231907A2 Dextrose and insulin fluid formulation for intravenous infusion |
| 08/21/2002 | EP1231903A2 Coating of tablet cores |
| 08/21/2002 | EP1231899A2 Multilayer preparation for a controlled, pulsed release of active substances |
| 08/21/2002 | EP1231898A2 Apparatus and method for preparing microparticles |
| 08/21/2002 | EP1154801A4 Integration of transplanted neural progenitor cells into neural tissue of immature and mature dystrophic recipients |
| 08/21/2002 | EP1041991A4 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha |
| 08/21/2002 | EP0756596B1 Tropane-2-aldoxime derivatives as neurotransmitter reuptake inhibitors |
| 08/21/2002 | EP0696194B1 Use of indole derivatives as 5ht1 antagonists |
| 08/21/2002 | EP0637203B1 Regulation of the immune system |
| 08/21/2002 | CN1365363A thineopyranecarboxyamide derivatives |
| 08/21/2002 | CN1365359A Benzofurylpiperazines and benzofurylhomopiperazines: serotonin agonists |
| 08/21/2002 | CN1365356A Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect |
| 08/21/2002 | CN1365285A Neurotrophic factors in the treatment of peripheral nerve dysfunction of pelvia area |
| 08/21/2002 | CN1365277A Method for treating chronic pain using MEK inhibitors |
| 08/21/2002 | CN1365276A Method for treating eating disorders |
| 08/21/2002 | CN1364812A Human glial cell derived neurotrophic factor and its derivatives and use |
| 08/21/2002 | CN1364641A Anti-drunk-enness and sobering up composition and its preparing method |
| 08/21/2002 | CN1364634A Medicament for curing insomnia |
| 08/21/2002 | CN1364590A Medicine for curing encephalatrophy |
| 08/21/2002 | CN1364587A Traditional Chinese medicine oral liquor for sobering up |
| 08/21/2002 | CN1364534A Nano eight ingredient ingredient and eagled wood medicine for clearing away pericardium heat and its preparing method |
| 08/21/2002 | CN1364525A Nano body strengthening and brain invigorating medicine and its preparing method |
| 08/21/2002 | CN1364524A Nano cow-bezoare medicine for clearing away heat-evil in pericardium and its preparing method |
| 08/21/2002 | CN1364509A Nano seventy ingredient pearl medicine and its preparing method |
| 08/21/2002 | CN1364507A Nano seven ingredient axially choerospondias fruit medicine and its preparing method |
| 08/21/2002 | CN1364504A nano seven ingredient medicine and its preparing method |
| 08/21/2002 | CN1364501A Nano ginseng schisandra fruit medicine and its preparing method |
| 08/21/2002 | CN1364487A Nano fifteen ingredient eagle wood medicine and its preparing method |
| 08/21/2002 | CN1364486A Nano ten ingredient restoration medicine and its preparing method |
| 08/21/2002 | CN1364482A Nano wild jujube seed mecicine and its preparing method |
| 08/21/2002 | CN1364479A Nano gastrodia tuber and fleece-flower root medicine and its preparing method |
| 08/21/2002 | CN1364465A Medicine for curing epilepsy |
| 08/21/2002 | CN1364458A Controlled release hydroxy-ketone |
| 08/21/2002 | CN1089340C Oxa-and thia-diazole muscarinic receptor antagonists |
| 08/21/2002 | CN1089248C Medicine for curing diseases in nerve system and its preparing method |
| 08/21/2002 | CN1089245C Soy extract, process for its prepn. and pharmaceutical compsn. |
| 08/20/2002 | US6437165 Useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. |
| 08/20/2002 | US6437146 Mesangial proliferative glomerulonephritis |
| 08/20/2002 | US6437138 5-bromo-6-chloro-3-(2-(s)-azetidinyl or pyrrolidinyl-methoxy) pyridine intermediates for the 5-substituted compounds which are potent ligands at neuronal nicotinic cholinergic channel receptors, neurotransmitter controlling agents |
| 08/20/2002 | US6437111 Bone morphogenetic protein-11 (BMP-11) compositions |
| 08/20/2002 | US6437093 Methods of treatment comprising administration of Substance P |
| 08/20/2002 | US6436998 Administering amides having improved kinetics and reduced side effects; drug abuse, drug dependence |
| 08/20/2002 | US6436997 Endogenous nitric oxide synthesis under conditions of low oxygen tension |
| 08/20/2002 | US6436996 Administering exogenous sources to cells having apolipoprotein alleles, for prophylaxis of alzheimer's disease |
| 08/20/2002 | US6436984 Melatonergic drugs that release nitrogen oxide and melatonin, used for prophylaxis of cardiovascular/nervous system, muscular disorders, antiischemic/inflammatory agents, reperfusion injuries, anemia and alzheimer's disease |
| 08/20/2002 | US6436983 Treatment for alzheimer's disease |
| 08/20/2002 | US6436974 Heterocyclic amines used as antiepileptic, antiischemic, analgesic and anxiolytic agents; prophylaxis of dyskinesia, brain, nerveous system and sleep disorders |
| 08/20/2002 | US6436972 Pyridones and their use as modulators of serine hydrolase enzymes |
| 08/20/2002 | US6436967 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors |
| 08/20/2002 | US6436965 Inhibition of phosphodiesterase; 3-carbocyclic(alkyl)oxy-2-aryl(alkyl)aminocarbonyl-1-aryl(alkyl)indole or azaindole derivatives |
| 08/20/2002 | US6436964 Piperidine derivatives having effects on serotonin related systems |
| 08/20/2002 | US6436957 Indole derivatives as 5-HT1 agonists |
| 08/20/2002 | US6436954 Benzo(b)quinolizidine and benzo(f)indolizidine derivatives useful for the treatment of alzheimer's disease, senile dementia or other conditions characterized by memory loss; pyrrolo(1,2-b)isoquinolines, benzo(b)quinolizines |
| 08/20/2002 | US6436949 Heterocyclically substituted benzamides and their use |
| 08/20/2002 | US6436942 Enantiomers of 1[(4-chloro-phenyl) phenylmethyl]-4-[(4-methylphenyl) sulfony]piperazine |
| 08/20/2002 | US6436941 Treating schizophrenia, depression, and parkinson's disease; side effect reduction |
| 08/20/2002 | US6436938 Combination treatment for depression |
| 08/20/2002 | US6436937 Use of desoxypeganine in the treatment of Alzheimer's dementia |
| 08/20/2002 | US6436932 Psychiatric disorders and neurological diseases; corticotropin releasing factor; pyrrolo(2,3-d)pyrimidine derivatives |
| 08/20/2002 | US6436925 Better able to cross membranes; inhibitors of cysteine proteases like calpain i and ii and cathepsin b and l, can thus be used to control diseases associated with an elevated activity of calpain enzymes or cathepsin enzymes |
| 08/20/2002 | US6436923 Compounds and methods for modulation of estrogen receptors |
| 08/20/2002 | US6436684 Isolated nucleic acid molecule consisting of selected nucleotide sequence encoding phenol sulfotransferase protein |
| 08/20/2002 | US6436438 Tramadol multiple unit formulations |
| 08/20/2002 | US6436437 Covalent polar lipid conjugates with neurologically active compounds for targeting |
| 08/20/2002 | US6436430 Self-emulsifying compositions for drugs poorly soluble in water |
| 08/20/2002 | US6436401 Administering the combination of anti-glutamic acid decarboxylase (anti-gad) antibody and anti-insulin antibody in amount effective to treat or prevent diabetes |
| 08/20/2002 | CA2291072C Method for the preparation of citalopram |
| 08/20/2002 | CA2252895C Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2(1h)-indol-2-one (=ziprasidone), its preparation and its use as dopamine d2 antagonist |